Truist Securities Downgrades Evolent Health (EVH) to Hold

June 30, 2026 2:47 AM

Truist Securities analyst Jailendra Singh downgraded Evolent Health (NYSE: EVH) from Buy to Hold with a price target of $7.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found